MMP2 and type 1 diabetes mellitus: Consistent with the higher levels of MT1-MMP expression in MDCK-T1 and MDCK-T1D cells, ConA treatment of these cells resulted in appearance of active MMP-2 (∼62 kDa) in the supernatant, as determined by immunoblot analyses and zymography (Fig. 5B and 5C).